Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Subarna Roy, Subhadeep Sen, Samiran Saha, Sandip Kumar Deb, Bhagat Singh & Goutam Biswas. (2023) Design, synthesis and molecular docking studies of 5-fluoro 1-aryl/alkyl sulfonyl benzimidazole derivatives for treatment of Parkinson’s disease. Phosphorus, Sulfur, and Silicon and the Related Elements 198:4, pages 336-344.
Read now
Read now
Madhwi Ojha, Avinash Kumar, Chakrawarti Prasun, Maya S. Nair, Saurabh Chaturvedi, Sarvesh Kumar Paliwal & Sumitra Nain. (2023) Synthesis, characterization, and in silico studies of 1,8-naphthyridine derivatives as potential anti-Parkinson’s agents. Journal of Biomolecular Structure and Dynamics 41:3, pages 805-820.
Read now
Read now
Elena García Esteban, María José Cózar-Bernal, Antonio M. Rabasco Álvarez & María Luisa González-Rodríguez. (2018) A comparative study of stabilising effect and antioxidant activity of different antioxidants on levodopa-loaded liposomes. Journal of Microencapsulation 35:4, pages 357-371.
Read now
Read now
Articles from other publishers (31)
Rita Caridade-Silva, Bruna Araújo, Joana Martins-Macedo & Fábio G. Teixeira. (2023) N-Acetylcysteine Treatment May Compensate Motor Impairments through Dopaminergic Transmission Modulation in a Striatal 6-Hydroxydopamine Parkinson’s Disease Rat Model. Antioxidants 12:6, pages 1257.
Crossref
Crossref
Mohammad Taghizadieh, Navid Modiri, Arash Salmaninejad, Reza Khayami, Forough Taheri, Mohsen Moghoofei, Alireza Khatami, Sara Azhdari, Mobina Bayat, Abbas Samadi-khouzani & Javid Sadri Nahand. 2023. Phytonutrients and Neurological Disorders. Phytonutrients and Neurological Disorders
133
200
.
Md. Mominur Rahman, Xiaoyan Wang, Md. Rezaul Islam, Shopnil Akash, Fatema Akter Supti, Mohona Islam Mitu, Md. Harun-Or-Rashid, Most. Nazmin Aktar, Most. Sumaiya Khatun Kali, Farhana Israt Jahan, Rajeev K. Singla, Bairong Shen, Abdur Rauf & Rohit Sharma. (2022) Multifunctional role of natural products for the treatment of Parkinson’s disease: At a glance. Frontiers in Pharmacology 13.
Crossref
Crossref
Sue-Jin Lin, Rafael Rodriguez-Rojas, Tobias R. Baumeister, Christophe Lenglos, Jose A. Pineda-Pardo, Jorge U. Máñez-Miró, Marta del Alamo, Raul Martinez-Fernandez, Jose A. Obeso & Yasser Iturria-Medina. (2022) Neuroimaging signatures predicting motor improvement to focused ultrasound subthalamotomy in Parkinson’s disease. npj Parkinson's Disease 8:1.
Crossref
Crossref
Charles Gnanaraj, Mahendran Sekar, Shivkanya Fuloria, Shasank S. Swain, Siew Hua Gan, Kumarappan Chidambaram, Nur Najihah Izzati Mat Rani, Tavamani Balan, Sarah Stephenie, Pei Teng Lum, Srikanth Jeyabalan, M. Yasmin Begum, Vivek Chandramohan, Lakshmi Thangavelu, Vetriselvan Subramaniyan & Neeraj Kumar Fuloria. (2022) In Silico Molecular Docking Analysis of Karanjin against Alzheimer’s and Parkinson’s Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy. Molecules 27:9, pages 2834.
Crossref
Crossref
Pedro Cruz-Vicente, Luís A. Passarinha, Samuel Silvestre & Eugenia Gallardo. (2021) Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches. Molecules 26:8, pages 2193.
Crossref
Crossref
Verónica Montiel Terrón, María Vitoria, Jose María Lamo de Espinosa Vázquez de Sola, Juan Ramón Valentí Nin & Andrés Valentí Azcárate. (2020) Do we really improve life quality after total knee arthroplasty in patients with Parkinson’s disease?. Archives of Orthopaedic and Trauma Surgery 141:2, pages 313-319.
Crossref
Crossref
Soshana P. Svendsen & Clive N. Svendsen. 2021. Neurotherapeutics in the Era of Translational Medicine. Neurotherapeutics in the Era of Translational Medicine
105
133
.
Ralph Buchert, Carsten Buhmann, Ivayla Apostolova, Philipp T. Meyer & Jürgen Gallinat. (2019) Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes. Deutsches Ärzteblatt international.
Crossref
Crossref
Ya-Yi Chen, Hueng-Chuen Fan, Min-Che Tung & Yu-Kang Chang. (2019) The association between Parkinson’s disease and temporomandibular disorder. PLOS ONE 14:6, pages e0217763.
Crossref
Crossref
Alex France M. Monteiro, Jéssika De O. Viana, Anuraj Nayarisseri, Ernestine N. Zondegoumba, Francisco Jaime B. Mendonça Junior, Marcus Tullius Scotti & Luciana Scotti. (2018) Computational Studies Applied to Flavonoids against Alzheimer’s and Parkinson’s Diseases. Oxidative Medicine and Cellular Longevity 2018, pages 1-21.
Crossref
Crossref
Augusta Pisanu, Laura Boi, Giovanna Mulas, Saturnino Spiga, Sandro Fenu & Anna R. Carta. (2018) Neuroinflammation in l-DOPA-induced dyskinesia: beyond the immune function. Journal of Neural Transmission 125:8, pages 1287-1297.
Crossref
Crossref
Daniel Stoessel, Claudia Schulte, Marcia C. Teixeira dos Santos, Dieter Scheller, Irene Rebollo-Mesa, Christian Deuschle, Dirk Walther, Nicolas Schauer, Daniela Berg, Andre Nogueira da Costa & Walter Maetzler. (2018) Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease. Frontiers in Aging Neuroscience 10.
Crossref
Crossref
Fábio G. Teixeira, Miguel F. Gago, Paulo Marques, Pedro Silva Moreira, Ricardo Magalhães, Nuno Sousa & António J. Salgado. (2018) Safinamide: a new hope for Parkinson’s disease?. Drug Discovery Today 23:3, pages 736-744.
Crossref
Crossref
Wolfgang H. Jost & Jennifer Bausch. (2017) Patients’ perspective on current treatment options for Parkinson’s Disease. Basal Ganglia 9, pages 7-11.
Crossref
Crossref
Arif Dalvi, Rajesh Pahwa & Kelly E. Lyons. 2017. Movement Disorders Curricula. Movement Disorders Curricula
303
314
.
Yinxiu Ding, Zixin Zhang, Jiangbo Ma, Hechun Xia, Yin Wang, Yinming Liu, Quanrui Ma, Tao Sun & Juan Liu. (2016) Directed differentiation of postnatal hippocampal neural stem cells generates nuclear receptor related-1 protein- and tyrosine hydroxylase-expressing cells. Molecular Medicine Reports 14:3, pages 1993-1999.
Crossref
Crossref
Junfeng ZhangHongying Tan, Wei Jiang & Zhiyi Zuo. (2014) Amantadine Alleviates Postoperative Cognitive Dysfunction Possibly by Increasing Glial Cell Line-derived Neurotrophic Factor in Rats. Anesthesiology 121:4, pages 773-785.
Crossref
Crossref
Lianbo Gao, Honghua Gao, Huan Zhou & Yanyuan Xu. (2013) RETRACTED ARTICLE: Gene expression profiling analysis of the putamen for the investigation of compensatory mechanisms in Parkinson’s disease. BMC Neurology 13:1.
Crossref
Crossref
. 2013. Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders. Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders
1
52
.
Elena M. Vazey & Gary Aston-Jones. (2013) New tricks for old dogmas: Optogenetic and designer receptor insights for Parkinson's disease. Brain Research 1511, pages 153-163.
Crossref
Crossref
Rajeswara Babu Mythri, Shireen Vali & M. M. Srinivas Bharath. 2013. Encyclopedia of Systems Biology. Encyclopedia of Systems Biology
589
592
.
Jong-Heon Kim, Ho-Won Lee, Jaegyu Hwang, Jaehong Kim, Min-Jeong Lee, Hyung-Soo Han, Won-Ha Lee & Kyoungho Suk. (2012) Microglia-inhibiting activity of Parkinson's disease drug amantadine. Neurobiology of Aging 33:9, pages 2145-2159.
Crossref
Crossref
Yang Chen, Fei Liu, Bing Yang, Anrui Lu, Shiwei Wang, Jingfang Wang, Qing-Zhi Ling, Xuan Li, Brenda T. Beerntsen & Erjun Ling. (2012) Specific amino acids affecting Drosophila melanogaster prophenoloxidase activity in vitro. Developmental & Comparative Immunology 38:1, pages 88-97.
Crossref
Crossref
Ruiping Xia & Zhi-Hong Mao. (2012) Progression of motor symptoms in Parkinson’s disease. Neuroscience Bulletin 28:1, pages 39-48.
Crossref
Crossref
Bernardino Ossola, Nadia Schendzielorz, Shih-Heng Chen, Gary S. Bird, Raimo K. Tuominen, Pekka T. Männistö & Jau-Shyong Hong. (2011) Amantadine protects dopamine neurons by a dual action: Reducing activation of microglia and inducing expression of GNDF in astroglia. Neuropharmacology 61:4, pages 574-582.
Crossref
Crossref
Andrea J Lindahl & Doug MacMahon. (2011) Parkinson's: treating the symptoms. British Journal of Nursing 20:14, pages 852-857.
Crossref
Crossref
Paul M. Gallo & Carol Ewing Garber. (2011) PARKINSON’S DISEASE. ACSM'S Health & Fitness Journal 15:4, pages 8-17.
Crossref
Crossref
Arif Dalvi. (2011) Medical Treatment of Tremor. Disease-a-Month 57:3, pages 135-141.
Crossref
Crossref
Ramiro Antonio Perez de la Torre & Agustín Dorantes-Argandar. (2011) Surgical Management of Parkinson Disease. Contemporary Neurosurgery 33:2, pages 1-6.
Crossref
Crossref
Rajeswara Babu Mythri, G. Harish, Shiv Kumar Dubey, Krishna Misra & M. M. Srinivas Bharath. (2010) Glutamoyl diester of the dietary polyphenol curcumin offers improved protection against peroxynitrite-mediated nitrosative stress and damage of brain mitochondria in vitro: implications for Parkinson’s disease. Molecular and Cellular Biochemistry 347:1-2, pages 135-143.
Crossref
Crossref